{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:58:52Z","timestamp":1792828732828,"version":"4.5.0"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T00:00:00Z","timestamp":1596326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T00:00:00Z","timestamp":1596326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Recurrence after pituitary surgery in Cushing\u2019s disease (CD) is a common problem ranging from 5% (minimum) to 50% (maximum) after initially successful surgery, respectively. In this review, we give an overview of the current literature regarding prevalence, diagnosis, and therapeutic options of recurrent CD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We systematically screened the literature regarding recurrent and persistent Cushing\u2019s disease using the MESH term\n                      <jats:italic>Cushing\u2019s disease and recurrence<\/jats:italic>\n                      . Of 717 results in PubMed, all manuscripts in English and German published between 1980 and April 2020 were screened. Case reports, comments, publications focusing on pediatric CD or CD in veterinary disciplines or studies with very small sample size (patient number\u2009&lt;\u200910) were excluded. Also, papers on CD in pregnancy were not included in this review.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and conclusions<\/jats:title>\n                    <jats:p>Because of the high incidence of recurrence in CD, annual clinical and biochemical follow-up is paramount. 50% of recurrences occur during the first 50 months after first surgery. In case of recurrence, treatment options include second surgery, pituitary radiation, targeted medical therapy to control hypercortisolism, and bilateral adrenalectomy. Success rates of all these treatment options vary between 25 (some of the medical therapy) and 100% (bilateral adrenalectomy). All treatment options have specific advantages, limitations, and side effects. Therefore, treatment decisions have to be individualized according to the specific needs of the patient.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12020-020-02432-z","type":"journal-article","created":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T16:02:31Z","timestamp":1596384151000},"page":"218-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Recurrence after pituitary surgery in adult Cushing\u2019s disease: a systematic review on diagnosis and treatment"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4963-5184","authenticated-orcid":false,"given":"Leah T.","family":"Braun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Zopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Schmid-Tannwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat Pazos","family":"Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Honegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Ladurner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,2]]},"reference":[{"issue":"9522","key":"2432_CR1","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/s0140-6736(06)68699-6","volume":"367","author":"J Newell-Price","year":"2006","unstructured":"J. Newell-Price, X. Bertagna, A.B. Grossman, L.K. Nieman, Cushing\u2019s syndrome. Lancet (London, England) 367(9522), 1605\u20131617 (2006). https:\/\/doi.org\/10.1016\/s0140-6736(06)68699-6","journal-title":"Lancet (London, England)"},{"issue":"1","key":"2432_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11102-011-0347-7","volume":"15","author":"F Roelfsema","year":"2012","unstructured":"F. Roelfsema, N.R. Biermasz, A.M. Pereira, Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary 15(1), 71\u201383 (2012). https:\/\/doi.org\/10.1007\/s11102-011-0347-7","journal-title":"Pituitary"},{"issue":"5","key":"2432_CR3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s11102-018-0893-3","volume":"21","author":"LHA Broersen","year":"2018","unstructured":"L.H.A. Broersen, N.R. Biermasz, W.R. van Furth, F. de Vries, M.J.T. Verstegen, O.M. Dekkers, A.M. Pereira, Endoscopic vs. microscopic transsphenoidal surgery for Cushing\u2019s disease: a systematic review and meta-analysis. Pituitary 21(5), 524\u2013534 (2018). https:\/\/doi.org\/10.1007\/s11102-018-0893-3","journal-title":"Pituitary"},{"issue":"6","key":"2432_CR4","doi-asserted-by":"publisher","first-page":"R227","DOI":"10.1530\/eje-14-0883","volume":"172","author":"S Petersenn","year":"2015","unstructured":"S. Petersenn, A. Beckers, D. Ferone, A. van der Lely, J. Bollerslev, M. Boscaro, T. Brue, P. Bruzzi, F.F. Casanueva, P. Chanson, A. Colao, M. Reincke, G. Stalla, S. Tsagarakis, Therapy of endocrine disease: outcomes in patients with Cushing\u2019s disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence. Eur J Endocrinol. 172(6), R227\u2013R239 (2015). https:\/\/doi.org\/10.1530\/eje-14-0883","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2432_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1210\/jc.2005-1204","volume":"91","author":"F Esposito","year":"2006","unstructured":"F. Esposito, J.R. Dusick, P. Cohan, P. Moftakhar, D. McArthur, C. Wang, R.S. Swerdloff, D.F. Kelly, Clinical review: early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 91(1), 7\u201313 (2006). https:\/\/doi.org\/10.1210\/jc.2005-1204","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"2432_CR6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1365-2265.2005.02380.x","volume":"63","author":"AB Atkinson","year":"2005","unstructured":"A.B. Atkinson, A. Kennedy, M.I. Wiggam, D.R. McCance, B. Sheridan, Long-term remission rates after pituitary surgery for Cushing\u2019s disease: the need for long-term surveillance. Clin. Endocrinol. 63(5), 549\u2013559 (2005). https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02380.x","journal-title":"Clin. Endocrinol."},{"issue":"11","key":"2432_CR7","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1210\/jcem.80.11.7593411","volume":"80","author":"D Bochicchio","year":"1995","unstructured":"D. Bochicchio, M. Losa, M. Buchfelder, Factors influencing the immediate and late outcome of Cushing\u2019s disease treated by transsphenoidal surgery: a retrospective study by the European Cushing\u2019s Disease Survey Group. J. Clin. Endocrinol. Metab. 80(11), 3114\u20133120 (1995). https:\/\/doi.org\/10.1210\/jcem.80.11.7593411","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"2432_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.endonu.2012.09.009","volume":"60","author":"P Abell\u00e1n Galiana","year":"2013","unstructured":"P. Abell\u00e1n Galiana, C. Fajardo Monta\u00f1ana, P.A. Riesgo Su\u00e1rez, J. G\u00f3mez Vela, C.M. Escriv\u00e1, V.R. Lillo, [Predictors of long-term remission after transsphenoidal surgery in Cushing\u2019s disease]. Endocrinol. Nut. 60(8), 475\u2013482 (2013). https:\/\/doi.org\/10.1016\/j.endonu.2012.09.009","journal-title":"Endocrinol. Nut."},{"issue":"2","key":"2432_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11060-014-1508-0","volume":"119","author":"A Ayala","year":"2014","unstructured":"A. Ayala, A.J. Manzano, Detection of recurrent Cushing\u2019s disease: proposal for standardized patient monitoring following transsphenoidal surgery. J Neuro-oncol. 119(2), 235\u2013242 (2014). https:\/\/doi.org\/10.1007\/s11060-014-1508-0","journal-title":"J Neuro-oncol."},{"issue":"3","key":"2432_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1530\/eje-11-1095","volume":"167","author":"RA Feelders","year":"2012","unstructured":"R.A. Feelders, S.J. Pulgar, A. Kempel, A.M. Pereira, The burden of Cushing\u2019s disease: clinical and health-related quality of life aspects. Eur. J Endocrinol. 167(3), 311\u2013326 (2012). https:\/\/doi.org\/10.1530\/eje-11-1095","journal-title":"Eur. J Endocrinol."},{"issue":"4","key":"2432_CR11","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s11102-012-0455-z","volume":"16","author":"N Hameed","year":"2013","unstructured":"N. Hameed, C.G. Yedinak, J. Brzana, S.H. Gultekin, N.D. Coppa, A. Dogan, J.B. Delashaw, M. Fleseriu, Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing\u2019s disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience. Pituitary 16(4), 452\u2013458 (2013). https:\/\/doi.org\/10.1007\/s11102-012-0455-z","journal-title":"Pituitary"},{"key":"2432_CR12","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3389\/fendo.2019.00740","volume":"10","author":"JM Hinojosa-Amaya","year":"2019","unstructured":"J.M. Hinojosa-Amaya, E.V. Varlamov, S. McCartney, M. Fleseriu, Hypercortisolemia recurrence in cushing\u2019s disease; a diagnostic challenge. Front. Endocrinol. 10, 740\u2013740 (2019). https:\/\/doi.org\/10.3389\/fendo.2019.00740","journal-title":"Front. Endocrinol."},{"issue":"5","key":"2432_CR13","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1001\/archinte.1992.00400170067013","volume":"152","author":"AH Tahir","year":"1992","unstructured":"A.H. Tahir, L.R. Sheeler, Recurrent Cushing\u2019s disease after transsphenoidal surgery. Arch. Intern. Med. 152(5), 977\u2013981 (1992)","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"2432_CR14","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.clineuro.2008.12.011","volume":"111","author":"E Fomekong","year":"2009","unstructured":"E. Fomekong, D. Maiter, C. Grandin, C. Raftopoulos, Outcome of transsphenoidal surgery for Cushing\u2019s disease: a high remission rate in ACTH-secreting macroadenomas. Clin. Neurol. Neurosurg. 111(5), 442\u2013449 (2009). https:\/\/doi.org\/10.1016\/j.clineuro.2008.12.011","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"3-4","key":"2432_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.wneu.2011.06.033","volume":"77","author":"S Yamada","year":"2012","unstructured":"S. Yamada, N. Fukuhara, H. Nishioka, A. Takeshita, N. Inoshita, J. Ito, Y. Takeuchi, Surgical management and outcomes in patients with Cushing disease with negative pituitary magnetic resonance imaging. World Neurosurg. 77(3-4), 525\u2013532 (2012). https:\/\/doi.org\/10.1016\/j.wneu.2011.06.033","journal-title":"World Neurosurg."},{"issue":"8","key":"2432_CR16","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1590\/s0004-27302007000800011","volume":"51","author":"NM Albiger","year":"2007","unstructured":"N.M. Albiger, C.M. Scaroni, F. Mantero, Cyclic Cushing\u2019s syndrome: an overview. Arq. Brasileiros de Endocrinol. e Metabologia 51(8), 1253\u20131260 (2007). https:\/\/doi.org\/10.1590\/s0004-27302007000800011","journal-title":"Arq. Brasileiros de Endocrinol. e Metabologia"},{"issue":"8","key":"2432_CR17","doi-asserted-by":"publisher","first-page":"962","DOI":"10.4158\/EP171787.OR","volume":"23","author":"EB Geer","year":"2017","unstructured":"E.B. Geer, I. Shafiq, M.B. Gordon, V. Bonert, A. Ayala, R.S. Swerdloff, L. Katznelson, Y. Lalazar, E. Manuylova, K.J. Pulaski-Liebert, J.D. Carmichael, Z. Hannoush, V. Surampudi, M.S. Broder, D. Cherepanov, M. Eagan, J. Lee, Q. Said, M.P. Neary, B.M.K. Biller, Biochemical control during long-term follow-up of 230 adult patients with Cushing Disease: a multicenter retrospective study. Endocr. Pract. 23(8), 962\u2013970 (2017). https:\/\/doi.org\/10.4158\/EP171787.OR","journal-title":"Endocr. Pract."},{"key":"2432_CR18","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/j.wneu.2018.07.055","volume":"119","author":"C Brichard","year":"2018","unstructured":"C. Brichard, E. Costa, E. Fomekong, D. Maiter, C. Raftopoulos, Outcome of transsphenoidal surgery for cushing disease: a single-center experience over 20 Years. World Neurosurg. 119, e106\u2013e117 (2018). https:\/\/doi.org\/10.1016\/j.wneu.2018.07.055","journal-title":"World Neurosurg."},{"issue":"4","key":"2432_CR19","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4158\/ep15922.ra","volume":"22","author":"AM Abu Dabrh","year":"2016","unstructured":"A.M. Abu Dabrh, N.M. Singh Ospina, A. Al Nofal, W.H. Farah, P. Barrionuevo, M. Sarigianni, A.B. Mohabbat, K. Benkhadra, B.G. Carranza Leon, M.R. Gionfriddo, Z. Wang, K. Mohammed, A.T. Ahmed, T.A. Elraiyah, Q. Haydour, F. Alahdab, L.J. Prokop, M.H. Murad, Predictors of biochemical remission and recurrence after surgical and radiation treatments of Cushing disease: a systematic review and meta-analysis. Endocr. Pract. 22(4), 466\u2013475 (2016). https:\/\/doi.org\/10.4158\/ep15922.ra","journal-title":"Endocr. Pract."},{"issue":"10","key":"2432_CR20","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1210\/jc.2003-030461","volume":"88","author":"FG Barker 2nd","year":"2003","unstructured":"F.G. Barker 2nd, A. Klibanski, B. Swearingen, Transsphenoidal surgery for pituitary tumors in the United States, 1996\u20132000: mortality, morbidity, and the effects of hospital and surgeon volume. J. Clin. Endocrinol. Metab. 88(10), 4709\u20134719 (2003). https:\/\/doi.org\/10.1210\/jc.2003-030461","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"2432_CR21","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1046\/j.1365-2265.2001.01261.x","volume":"54","author":"GH Chee","year":"2001","unstructured":"G.H. Chee, D.B. Mathias, R.A. James, P. Kendall-Taylor, Transsphenoidal pituitary surgery in Cushing\u2019s disease: can we predict outcome? Clin. Endocrinol. 54(5), 617\u2013626 (2001). https:\/\/doi.org\/10.1046\/j.1365-2265.2001.01261.x","journal-title":"Clin. Endocrinol."},{"key":"2432_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-015-0055-9","volume":"15","author":"J Ramm-Pettersen","year":"2015","unstructured":"J. Ramm-Pettersen, H. Halvorsen, J.A. Evang, P. R\u00f8nning, P.K. Hol, J. Bollerslev, J. Berg-Johnsen, E. Helseth, Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing\u2019s disease. BMC Endocr. Disord. 15, 62 (2015). https:\/\/doi.org\/10.1186\/s12902-015-0055-9","journal-title":"BMC Endocr. Disord."},{"issue":"1","key":"2432_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1046\/j.0300-0664.2001.01444.x","volume":"56","author":"LB Yap","year":"2002","unstructured":"L.B. Yap, H.E. Turner, C.B. Adams, J.A. Wass, Undetectable postoperative cortisol does not always predict long-term remission in Cushing\u2019s disease: a single centre audit. Clin. Endocrinol. 56(1), 25\u201331 (2002). https:\/\/doi.org\/10.1046\/j.0300-0664.2001.01444.x","journal-title":"Clin. Endocrinol."},{"issue":"12","key":"2432_CR24","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1210\/jc.2003-030751","volume":"88","author":"AM Pereira","year":"2003","unstructured":"A.M. Pereira, M.O. van Aken, H. van Dulken, P.J. Schutte, N.R. Biermasz, J.W. Smit, F. Roelfsema, J.A. Romijn, Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 88(12), 5858\u20135864 (2003). https:\/\/doi.org\/10.1210\/jc.2003-030751","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2432_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000496753","volume":"108","author":"Y Liu","year":"2019","unstructured":"Y. Liu, X. Liu, X. Hong, P. Liu, X. Bao, Y. Yao, B. Xing, Y. Li, Y. Huang, H. Zhu, L. Lu, R. Wang, M. Feng, Prediction of recurrence after transsphenoidal surgery for cushing\u2019s disease: the use of machine learning algorithms. Neuroendocrinology 108(3), 201\u2013210 (2019). https:\/\/doi.org\/10.1159\/000496753","journal-title":"Neuroendocrinology"},{"issue":"6","key":"2432_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jfma.2016.08.008","volume":"116","author":"C-H Kuo","year":"2017","unstructured":"C.-H. Kuo, S.-R. Shih, H.-Y. Li, S.-C. Chen, P.-J. Hung, F.-Y. Tseng, T.-C. Chang, Adrenocorticotropic hormone levels before treatment predict recurrence of Cushing\u2019s disease. J. Formos Med. Assoc. 116(6), 441\u2013447 (2017). https:\/\/doi.org\/10.1016\/j.jfma.2016.08.008","journal-title":"J. Formos Med. Assoc."},{"key":"2432_CR27","doi-asserted-by":"publisher","unstructured":"A. Albani, L.G. Perez-Rivas, C. Dimopoulou, S. Zopp, P. Colon-Bolea, S. Roeber, J. Honegger, J. Flitsch, W. Rachinger, M. Buchfelder, G.K. Stalla, J. Herms, M. Reincke, M. Theodoropoulou, The USP8 mutational status may predict long-term remission in patients with Cushing\u2019s disease. Clin. Endocrinol. (2018). https:\/\/doi.org\/10.1111\/cen.13802","DOI":"10.1111\/cen.13802"},{"issue":"4","key":"2432_CR28","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1210\/jc.2014-3632","volume":"100","author":"CM Berr","year":"2015","unstructured":"C.M. Berr, G. Di Dalmazi, A. Osswald, K. Ritzel, M. Bidlingmaier, L.L. Geyer, M. Treitl, K. Hallfeldt, W. Rachinger, N. Reisch, R. Blaser, J. Schopohl, F. Beuschlein, M. Reincke, Time to recovery of adrenal function after curative surgery for Cushing\u2019s syndrome depends on etiology. J. Clin. Endocrinol. Metab. 100(4), 1300\u20131308 (2015). https:\/\/doi.org\/10.1210\/jc.2014-3632","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"2432_CR29","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1210\/jc.2007-0208","volume":"92","author":"N Pouratian","year":"2007","unstructured":"N. Pouratian, D.M. Prevedello, J. Jagannathan, M.B. Lopes, M.L. Vance, E.R. Laws Jr, Outcomes and management of patients with Cushing\u2019s disease without pathological confirmation of tumor resection after transsphenoidal surgery. J. Clin. Endocrinol. Metab. 92(9), 3383\u20133388 (2007). https:\/\/doi.org\/10.1210\/jc.2007-0208","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2432_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0090-3019(99)00159-7","volume":"53","author":"K Hague","year":"2000","unstructured":"K. Hague, K.D. Post, S. Morgello, Absence of peritumoral Crooke\u2019s change is associated with recurrence in surgically treated Cushing\u2019s disease. Surg. Neurol. 53(1), 77\u201381 (2000)","journal-title":"Surg. Neurol."},{"issue":"1","key":"2432_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11060-018-03078-8","volume":"142","author":"D Cordeiro","year":"2019","unstructured":"D. Cordeiro, Z. Xu, M. Nasser, B. Lopes, M.L. Vance, J. Sheehan, The role of Crooke\u2019s changes in recurrence and remission after gamma knife radiosurgery. J. Neuro-oncol. 142(1), 171\u2013181 (2019). https:\/\/doi.org\/10.1007\/s11060-018-03078-8","journal-title":"J. Neuro-oncol."},{"issue":"11","key":"2432_CR32","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/jclinpath-2018-205226","volume":"71","author":"M Peck","year":"2018","unstructured":"M. Peck, D. Moffat, B. Latham, T. Badrick, Review of diagnostic error in anatomical pathology and the role and value of second opinions in error prevention. J. Clin. Pathol. 71(11), 995\u20131000 (2018). https:\/\/doi.org\/10.1136\/jclinpath-2018-205226","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"2432_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.17925\/ee.2015.11.01.34","volume":"11","author":"I Huguet","year":"2015","unstructured":"I. Huguet, G. Ntali, A. Grossman, N. Karavitaki, Cushing\u2019s disease - quality of life, recurrence and long-term morbidity. Eur. Endocrinol. 11(1), 34\u201338 (2015). https:\/\/doi.org\/10.17925\/ee.2015.11.01.34","journal-title":"Eur. Endocrinol."},{"issue":"12","key":"2432_CR34","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.4158\/ep161512.dscr","volume":"22","author":"M Fleseriu","year":"2016","unstructured":"M. Fleseriu, A.H. Hamrahian, A.R. Hoffman, D.F. Kelly, L. Katznelson, American association of clinical endocrinologists and American college of endocrinology disease state clinical review: diagnosis of recurrence in Cushing disease. Endocr. Pract. 22(12), 1436\u20131448 (2016). https:\/\/doi.org\/10.4158\/ep161512.dscr","journal-title":"Endocr. Pract."},{"issue":"4","key":"2432_CR35","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s11102-017-0801-2","volume":"20","author":"EB Geer","year":"2017","unstructured":"E.B. Geer, A. Ayala, V. Bonert, J.D. Carmichael, M.B. Gordon, L. Katznelson, E. Manuylova, I. Shafiq, V. Surampudi, R.S. Swerdloff, M.S. Broder, D. Cherepanov, M. Eagan, J. Lee, Q. Said, M.P. Neary, B.M.K. Biller, Follow-up intervals in patients with Cushing\u2019s disease: recommendations from a panel of experienced pituitary clinicians. Pituitary 20(4), 422\u2013429 (2017). https:\/\/doi.org\/10.1007\/s11102-017-0801-2","journal-title":"Pituitary"},{"issue":"2","key":"2432_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00701-009-0544-6","volume":"152","author":"T Psaras","year":"2010","unstructured":"T. Psaras, M. Milian, V. Hattermann, B. Gallwitz, T. Freiman, J. Honegger, Aftercare in patients with Cushing\u2019s disease and acromegaly: is there room for improvement? Acta Neurochirurgica 152(2), 271\u2013278 (2010). https:\/\/doi.org\/10.1007\/s00701-009-0544-6","journal-title":"Acta Neurochirurgica"},{"issue":"4","key":"2432_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11102-013-0511-3","volume":"17","author":"NK Sundaram","year":"2014","unstructured":"N.K. Sundaram, A. Carluccio, E.B. Geer, Characterization of persistent and recurrent Cushing\u2019s disease. Pituitary 17(4), 381\u2013391 (2014). https:\/\/doi.org\/10.1007\/s11102-013-0511-3","journal-title":"Pituitary"},{"issue":"2","key":"2432_CR38","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/cen.12534","volume":"82","author":"M Danet-Lamasou","year":"2015","unstructured":"M. Danet-Lamasou, J. Asselineau, P. Perez, A. Vivot, M.L. Nunes, H. Loiseau, F. San-Galli, B. Cherifi-Gatta, J.B. Corcuff, A. Tabarin, Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing\u2019s disease following pituitary surgery. Clin. Endocrinol. 82(2), 260\u2013266 (2015). https:\/\/doi.org\/10.1111\/cen.12534","journal-title":"Clin. Endocrinol."},{"issue":"10","key":"2432_CR39","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1210\/jc.2015-2107","volume":"100","author":"FG Amlashi","year":"2015","unstructured":"F.G. Amlashi, B. Swearingen, A.T. Faje, L.B. Nachtigall, K.K. Miller, A. Klibanski, B.M. Biller, N.A. Tritos, Accuracy of late-night salivary cortisol in evaluating postoperative remission and recurrence in cushing\u2019s disease. J. Clin. Endocrinol. Metab. 100(10), 3770\u20133777 (2015). https:\/\/doi.org\/10.1210\/jc.2015-2107","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"2432_CR40","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1210\/jc.2008-2234","volume":"94","author":"F Castinetti","year":"2009","unstructured":"F. Castinetti, M. Martinie, I. Morange, H. Dufour, N. Sturm, J.G. Passagia, B. Conte-Devolx, O. Chabre, T. Brue, A combined dexamethasone desmopressin test as an early marker of postsurgical recurrence in Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 94(6), 1897\u20131903 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"2432_CR41","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1530\/ec-17-0292","volume":"6","author":"AG Ambrogio","year":"2017","unstructured":"A.G. Ambrogio, M. Andrioli, M. De Martin, F. Cavagnini, F. Pecori Giraldi, Usefulness of desmopressin testing to predict relapse during long-term follow-up in patients in remission from Cushing\u2019s disease. Endocr. Connect. 6(8), 791\u2013799 (2017). https:\/\/doi.org\/10.1530\/ec-17-0292","journal-title":"Endocr. Connect."},{"issue":"5","key":"2432_CR42","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1530\/eje-19-0770","volume":"182","author":"S Cambos","year":"2020","unstructured":"S. Cambos, K. Mohammedi, F. Castinetti, C. Saie, J. Young, P. Chanson, A. Tabarin, Persistent cortisol response to desmopressin predicts recurrence of Cushing\u2019s disease in patients with post-operative corticotropic insufficiency. Eur. J. Endocrinol 182(5), 489\u2013498 (2020). https:\/\/doi.org\/10.1530\/eje-19-0770","journal-title":"Eur. J. Endocrinol"},{"issue":"6","key":"2432_CR43","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.3171\/jns.2002.97.6.1343","volume":"97","author":"RD Dickerman","year":"2002","unstructured":"R.D. Dickerman, E.H. Oldfield, Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery. J. Neurosurg. 97(6), 1343\u20131349 (2002). https:\/\/doi.org\/10.3171\/jns.2002.97.6.1343","journal-title":"J. Neurosurg."},{"issue":"6","key":"2432_CR44","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1227\/01.neu.0000215945.26764.92","volume":"58","author":"BM Hofmann","year":"2006","unstructured":"B.M. Hofmann, M. Hlavac, J. Kreutzer, G. Grabenbauer, R. Fahlbusch, Surgical treatment of recurrent Cushing\u2019s disease. Neurosurgery 58(6), 1108\u20131118 (2006). https:\/\/doi.org\/10.1227\/01.neu.0000215945.26764.92. discussion 1108\u20131118","journal-title":"Neurosurgery"},{"issue":"4","key":"2432_CR45","first-page":"690","volume":"21","author":"FS Bonelli","year":"2000","unstructured":"F.S. Bonelli, J. Huston 3rd, P.C. Carpenter, D. Erickson, W.F.Young Jr., F.B. Meyer, Adrenocorticotropic hormone-dependent Cushing\u2019s syndrome: sensitivity and specificity of inferior petrosal sinus sampling. Am. J. Neuroradiol. 21(4), 690\u2013696 (2000)","journal-title":"Am. J. Neuroradiol."},{"issue":"3","key":"2432_CR46","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s12020-016-1038-y","volume":"55","author":"G Vitale","year":"2017","unstructured":"G. Vitale, F. Tortora, R. Baldelli, F. Cocchiara, R.M. Paragliola, E. Sbardella, C. Simeoli, F. Caranci, R. Pivonello, A. Colao, Pituitary magnetic resonance imaging in Cushing\u2019s disease. Endocrine 55(3), 691\u2013696 (2017). https:\/\/doi.org\/10.1007\/s12020-016-1038-y","journal-title":"Endocrine"},{"issue":"3","key":"2432_CR47","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3171\/2017.4.jns17234","volume":"129","author":"GP Chatain","year":"2018","unstructured":"G.P. Chatain, N. Patronas, J.G. Smirniotopoulos, M. Piazza, S. Benzo, A. Ray-Chaudhury, S. Sharma, M. Lodish, L. Nieman, C.A. Stratakis, P. Chittiboina, Potential utility of FLAIR in MRI-negative Cushing\u2019s disease. J. Neurosurg. 129(3), 620\u2013628 (2018). https:\/\/doi.org\/10.3171\/2017.4.jns17234","journal-title":"J. Neurosurg."},{"issue":"4","key":"2432_CR48","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3171\/2017.3.jns163122","volume":"128","author":"Y Grober","year":"2018","unstructured":"Y. Grober, H. Grober, M. Wintermark, J.A. Jane, E.H. Oldfield, Comparison of MRI techniques for detecting microadenomas in Cushing\u2019s disease. J. Neurosurg. 128(4), 1051\u20131057 (2018). https:\/\/doi.org\/10.3171\/2017.3.jns163122","journal-title":"J. Neurosurg."},{"issue":"4","key":"2432_CR49","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3171\/2009.7.jns09285","volume":"112","author":"H Ikeda","year":"2010","unstructured":"H. Ikeda, T. Abe, K. Watanabe, Usefulness of composite methionine-positron emission tomography\/3.0-tesla magnetic resonance imaging to detect the localization and extent of early-stage Cushing adenoma. J. Neurosurg. 112(4), 750\u2013755 (2010). https:\/\/doi.org\/10.3171\/2009.7.jns09285","journal-title":"J. Neurosurg."},{"issue":"4","key":"2432_CR50","doi-asserted-by":"publisher","first-page":"M107","DOI":"10.1530\/eje-15-0616","volume":"173","author":"O Koulouri","year":"2015","unstructured":"O. Koulouri, A. Steuwe, D. Gillett, A.C. Hoole, A.S. Powlson, N.A. Donnelly, N.G. Burnet, N.M. Antoun, H. Cheow, R.J. Mannion, J.D. Pickard, M. Gurnell, A role for 11C-methionine PET imaging in ACTH-dependent Cushing\u2019s syndrome. Eur. J. Endocrinol. 173(4), M107\u2013M120 (2015). https:\/\/doi.org\/10.1530\/eje-15-0616","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"2432_CR51","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12020-019-01944-7","volume":"65","author":"J Boyle","year":"2019","unstructured":"J. Boyle, N.J. Patronas, J. Smirniotopoulos, P. Herscovitch, W. Dieckman, C. Millo, D. Maric, G.P. Chatain, C.P. Hayes, S. Benzo, G. Scott, N. Edwards, A. Ray Chaudhury, M.B. Lodish, S. Sharma, L.K. Nieman, C.A. Stratakis, R.R. Lonser, P. Chittiboina, CRH stimulation improves (18)F-FDG-PET detection of pituitary adenomas in Cushing\u2019s disease. Endocrine 65(1), 155\u2013165 (2019). https:\/\/doi.org\/10.1007\/s12020-019-01944-7","journal-title":"Endocrine"},{"issue":"4","key":"2432_CR52","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3171\/jns.1989.71.4.0520","volume":"71","author":"RB Friedman","year":"1989","unstructured":"R.B. Friedman, E.H. Oldfield, L.K. Nieman, G.P. Chrousos, J.L. Doppman, G.B. Cutler Jr., D.L. Loriaux, Repeat transsphenoidal surgery for Cushing\u2019s disease. J. Neurosurg. 71(4), 520\u2013527 (1989)","journal-title":"J. Neurosurg."},{"issue":"Suppl 1","key":"2432_CR53","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000314223","volume":"92","author":"M Buchfelder","year":"2010","unstructured":"M. Buchfelder, S. Schlaffer, Pituitary surgery for Cushing\u2019s disease. Neuroendocrinology 92(Suppl 1), 102\u2013106 (2010). https:\/\/doi.org\/10.1159\/000314223","journal-title":"Neuroendocrinology"},{"issue":"2","key":"2432_CR54","doi-asserted-by":"publisher","first-page":"101270","DOI":"10.1016\/j.beem.2019.04.004","volume":"33","author":"G Rubinstein","year":"2019","unstructured":"G. Rubinstein, A. Osswald, S. Zopp, K. Ritzel, M. Theodoropoulou, F. Beuschlein, M. Reincke, Therapeutic options after surgical failure in Cushing\u2019s disease: A critical review. Best practice & research. Clin. Endocrinol. Metab. 33(2), 101270 (2019). https:\/\/doi.org\/10.1016\/j.beem.2019.04.004","journal-title":"Clin. Endocrinol. Metab."},{"issue":"5","key":"2432_CR55","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s11102-018-0904-4","volume":"21","author":"J Honegger","year":"2018","unstructured":"J. Honegger, F. Grimm, The experience with transsphenoidal surgery and its importance to outcomes. Pituitary 21(5), 545\u2013555 (2018). https:\/\/doi.org\/10.1007\/s11102-018-0904-4","journal-title":"Pituitary"},{"issue":"4","key":"2432_CR56","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.endonu.2013.10.008","volume":"61","author":"P Valderr\u00e1bano","year":"2014","unstructured":"P. Valderr\u00e1bano, J. Aller, L. Garc\u00eda-Valdecasas, J. Garc\u00eda-Ur\u00eda, L. Mart\u00edn, N. Palacios, J. Estrada, Results of repeated transsphenoidal surgery in Cushing\u2019s disease. Long-term follow-up. Endocrinologia y nutricion: organo de la Sociedad Espanola de. Endocrinol. Nutr. 61(4), 176\u2013183 (2014). https:\/\/doi.org\/10.1016\/j.endonu.2013.10.008","journal-title":"Endocrinol. Nutr."},{"issue":"1","key":"2432_CR57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3171\/jns\/2008\/108\/01\/0009","volume":"108","author":"BM Hofmann","year":"2008","unstructured":"B.M. Hofmann, M. Hlavac, R. Martinez, M. Buchfelder, O.A. M\u00fcller, R. Fahlbusch, Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. J. Neurosurg. 108(1), 9\u201318 (2008). https:\/\/doi.org\/10.3171\/jns\/2008\/108\/01\/0009","journal-title":"J. Neurosurg."},{"issue":"2","key":"2432_CR58","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1227\/01.neu.0000313117.35824.9f","volume":"63","author":"CG Patil","year":"2008","unstructured":"C.G. Patil, A. Veeravagu, D.M. Prevedello, L. Katznelson, M.L. Vance, E.R. Laws Jr., Outcomes after repeat transsphenoidal surgery for recurrent Cushing\u2019s disease. Neurosurgery 63(2), 266\u2013270 (2008). https:\/\/doi.org\/10.1227\/01.neu.0000313117.35824.9f. discussion 270-261","journal-title":"Neurosurgery"},{"issue":"2","key":"2432_CR59","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2265.2008.03334.x","volume":"70","author":"MA Wagenmakers","year":"2009","unstructured":"M.A. Wagenmakers, R.T. Netea-Maier, E.J. van Lindert, H.J. Timmers, J.A. Grotenhuis, A.R. Hermus, Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing\u2019s disease (CD). Clin. Endocrinol. 70(2), 274\u2013280 (2009). https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03334.x","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"2432_CR60","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1210\/er.2013-1048","volume":"36","author":"R Pivonello","year":"2015","unstructured":"R. Pivonello, M. De Leo, A. Cozzolino, A. Colao, The treatment of cushing\u2019s disease. Endocr. Rev. 36(4), 385\u2013486 (2015). https:\/\/doi.org\/10.1210\/er.2013-1048","journal-title":"Endocr. Rev."},{"issue":"1","key":"2432_CR61","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/cen.14123","volume":"92","author":"K Thakkar","year":"2020","unstructured":"K. Thakkar, A. Lila, V. Sarathi, S. Ramteke-Jadhav, M. Goroshi, S.S. Memon, R. Krishnatry, T. Gupta, R. Jalali, A. Goel, A. Shah, S. Sankhe, V. Patil, T. Bandgar, N.S. Shah, Cabergoline may act as a radioprotective agent in Cushing\u2019s disease. Clin. Endocrinol. 92(1), 55\u201362 (2020). https:\/\/doi.org\/10.1111\/cen.14123","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"2432_CR62","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ecl.2018.01.002","volume":"47","author":"N Ironside","year":"2018","unstructured":"N. Ironside, C.J. Chen, C.C. Lee, D.M. Trifiletti, M.L. Vance, J.P. Sheehan, Outcomes of pituitary radiation for cushing\u2019s disease. Endocrinol. Metab. Clin. North Am. 47(2), 349\u2013365 (2018). https:\/\/doi.org\/10.1016\/j.ecl.2018.01.002","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"1","key":"2432_CR63","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11102-013-0466-4","volume":"17","author":"S Budyal","year":"2014","unstructured":"S. Budyal, A.R. Lila, R. Jalali, T. Gupta, R. Kasliwal, V.S. Jagtap, T. Bandgar, P. Menon, N.S. Shah, Encouraging efficacy of modern conformal fractionated radiotherapy in patients with uncured Cushing\u2019s disease. Pituitary 17(1), 60\u201367 (2014). https:\/\/doi.org\/10.1007\/s11102-013-0466-4","journal-title":"Pituitary"},{"issue":"1","key":"2432_CR64","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11060-007-9344-0","volume":"84","author":"G Minniti","year":"2007","unstructured":"G. Minniti, M. Osti, M.L. Jaffrain-Rea, V. Esposito, G. Cantore, R. Maurizi Enrici, Long-term follow-up results of postoperative radiation therapy for Cushing\u2019s disease. J. Neuro-oncol. 84(1), 79\u201384 (2007). https:\/\/doi.org\/10.1007\/s11060-007-9344-0","journal-title":"J. Neuro-oncol."},{"issue":"3","key":"2432_CR65","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1056\/NEJM199701163360303","volume":"336","author":"J Estrada","year":"1997","unstructured":"J. Estrada, M. Boronat, M. Mielgo, R. Magall\u00f3n, I. Millan, S. D\u00edez, T. Lucas, B. Barcel\u00f3, The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing\u2019s disease. New Engl. J. Med. 336(3), 172\u2013177 (1997)","journal-title":"New Engl. J. Med."},{"issue":"4","key":"2432_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/foc.2004.16.4.6","volume":"16","author":"SJ Hentschel","year":"2004","unstructured":"S.J. Hentschel, I.E. McCutcheon, Stereotactic radiosurgery for Cushing disease. Neurosurg. Focus 16(4), 1\u20137 (2004)","journal-title":"Neurosurg. Focus"},{"key":"2432_CR67","doi-asserted-by":"publisher","unstructured":"N.M. Oyesiku, Stereotactic radiosurgery for Cushing disease: a review. Neurosurg. Focus 23(6), E14 (2007). https:\/\/doi.org\/10.3171\/FOC-07\/12\/E14","DOI":"10.3171\/FOC-07\/12\/E14"},{"key":"2432_CR68","doi-asserted-by":"publisher","first-page":"e670","DOI":"10.1016\/j.wneu.2018.05.067","volume":"116","author":"MJ Shepard","year":"2018","unstructured":"M.J. Shepard, G.U. Mehta, Z. Xu, H. Kano, N. Sisterson, Y.-H. Su, M. Krsek, A.M. Nabeel, A. El-Shehaby, K.A. Kareem, N. Martinez-Moreno, D. Mathieu, B.J. McShane, K. Blas, D. Kondziolka, I. Grills, J.Y. Lee, R. Martinez-Alvarez, W.A. Reda, R. Liscak, C.-C. Lee, L.D. Lunsford, M. Lee Vance, J.P. Sheehan, Technique of whole-sellar stereotactic radiosurgery for cushing disease: results from a multicenter, international cohort study. World Neurosurg. 116, e670\u2013e679 (2018). https:\/\/doi.org\/10.1016\/j.wneu.2018.05.067","journal-title":"World Neurosurg."},{"issue":"5","key":"2432_CR69","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3171\/jns.2000.93.5.0738","volume":"93","author":"JM Sheehan","year":"2000","unstructured":"J.M. Sheehan, M.L. Vance, J.P. Sheehan, D.B. Ellegala, E.R. Laws Jr, Radiosurgery for Cushing\u2019s disease after failed transsphenoidal surgery. J. Neurosurg. 93(5), 738\u2013742 (2000). https:\/\/doi.org\/10.3171\/jns.2000.93.5.0738","journal-title":"J. Neurosurg."},{"issue":"11","key":"2432_CR70","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.1210\/jc.2017-01385","volume":"102","author":"GU Mehta","year":"2017","unstructured":"G.U. Mehta, D. Ding, M.R. Patibandla, H. Kano, N. Sisterson, Y.H. Su, M. Krsek, A.M. Nabeel, A. El-Shehaby, K.A. Kareem, N. Martinez-Moreno, D. Mathieu, B. McShane, K. Blas, D. Kondziolka, I. Grills, J.Y. Lee, R. Martinez-Alvarez, W.A. Reda, R. Liscak, C.C. Lee, L.D. Lunsford, M.L. Vance, J.P. Sheehan, Stereotactic radiosurgery for cushing disease: results of an international, multicenter study. The J. Clin. Endocrinol. Metab. 102(11), 4284\u20134291 (2017). https:\/\/doi.org\/10.1210\/jc.2017-01385","journal-title":"The J. Clin. Endocrinol. Metab."},{"key":"2432_CR71","first-page":"141","volume":"55","author":"MK Aghi","year":"2008","unstructured":"M.K. Aghi, J. Petit, P. Chapman, J. Loeffler, A. Klibanski, B.M. Biller, B. Swearingen, Management of recurrent and refractory Cushing\u2019s disease with reoperation and\/or proton beam radiosurgery. Clin. Neurosurg. 55, 141\u2013144 (2008)","journal-title":"Clin. Neurosurg."},{"key":"2432_CR72","doi-asserted-by":"publisher","first-page":"e425","DOI":"10.1016\/j.wneu.2018.01.057","volume":"112","author":"JM Moore","year":"2018","unstructured":"J.M. Moore, E. Sala, A. Amorin, H. Martinez Jr., A.C. Bhowmik, S.D. Chang, S.G. Soltys, G.R. Harsh, L. Katznelson, CyberKnife radiosurgery in the multimodal management of patients with cushing disease. World Neurosurg. 112, e425\u2013e430 (2018). https:\/\/doi.org\/10.1016\/j.wneu.2018.01.057","journal-title":"World Neurosurg"},{"issue":"3","key":"2432_CR73","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11060-018-2817-5","volume":"138","author":"GU Mehta","year":"2018","unstructured":"G.U. Mehta, D. Ding, A. Gupta, H. Kano, N.D. Sisterson, N. Martinez-Moreno, M. Kr\u0161ek, H.C. Yang, C.C. Lee, R. Li\u0161\u010d\u00e1k, R. Martinez-Alvarez, L.D. Lunsford, M.L. Vance, J.P. Sheehan, Repeat stereotactic radiosurgery for Cushing\u2019s disease: outcomes of an international, multicenter study. J. Neuro-oncol. 138(3), 519\u2013525 (2018). https:\/\/doi.org\/10.1007\/s11060-018-2817-5","journal-title":"J. Neuro-oncol."},{"key":"2432_CR74","doi-asserted-by":"publisher","unstructured":"A. Bunevicius, D. Sheehan, M. Lee Vance, D. Schlesinger, J.P. Sheehan, Outcomes of Cushing\u2019s disease following Gamma Knife radiosurgery: effect of a center\u2019s growing experience and era of treatment. J. Neurosurg. 1\u20138 (2020). https:\/\/doi.org\/10.3171\/2019.12.jns192743","DOI":"10.3171\/2019.12.jns192743"},{"issue":"6","key":"2432_CR75","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s11102-018-0897-z","volume":"21","author":"LHA Broersen","year":"2018","unstructured":"L.H.A. Broersen, M. Jha, N.R. Biermasz, A.M. Pereira, O.M. Dekkers, Effectiveness of medical treatment for Cushing\u2019s syndrome: a systematic review and meta-analysis. Pituitary 21(6), 631\u2013641 (2018). https:\/\/doi.org\/10.1007\/s11102-018-0897-z","journal-title":"Pituitary"},{"issue":"1","key":"2432_CR76","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s2213-8587(17)30326-1","volume":"6","author":"A Lacroix","year":"2018","unstructured":"A. Lacroix, F. Gu, W. Gallardo, R. Pivonello, Y. Yu, P. Witek, M. Boscaro, R. Salvatori, M. Yamada, L. Tauchmanova, M. Roughton, S. Ravichandran, S. Petersenn, B.M.K. Biller, J. Newell-Price, Efficacy and safety of once-monthly pasireotide in Cushing\u2019s disease: a 12 month clinical trial. Lancet Diabetes Endocrinol. 6(1), 17\u201326 (2018). https:\/\/doi.org\/10.1016\/s2213-8587(17)30326-1","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"2432_CR77","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11102-019-01021-2","volume":"23","author":"A Lacroix","year":"2020","unstructured":"A. Lacroix, F. Gu, J. Schopohl, A. Kandra, A.M. Pedroncelli, L. Jin, R. Pivonello, Pasireotide treatment significantly reduces tumor volume in patients with Cushing\u2019s disease: results from a Phase 3 study. Pituitary 23(3), 203\u2013211 (2020). https:\/\/doi.org\/10.1007\/s11102-019-01021-2","journal-title":"Pituitary"},{"issue":"12","key":"2432_CR78","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s40618-018-0936-7","volume":"41","author":"R Palui","year":"2018","unstructured":"R. Palui, J. Sahoo, S. Kamalanathan, S.S. Kar, S. Selvarajan, H. Durgia, Effect of cabergoline monotherapy in Cushing\u2019s disease: an individual participant data meta-analysis. J. Endocrinol. Investig. 41(12), 1445\u20131455 (2018). https:\/\/doi.org\/10.1007\/s40618-018-0936-7","journal-title":"J. Endocrinol. Investig."},{"issue":"2","key":"2432_CR79","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s11102-015-0692-z","volume":"19","author":"M Fleseriu","year":"2016","unstructured":"M. Fleseriu, R. Pivonello, J. Young, A.H. Hamrahian, M.E. Molitch, C. Shimizu, T. Tanaka, A. Shimatsu, T. White, A. Hilliard, C. Tian, N. Sauter, B.M. Biller, X. Bertagna, Osilodrostat, a potent oral 11beta-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing\u2019s disease. Pituitary 19(2), 138\u2013148 (2016). https:\/\/doi.org\/10.1007\/s11102-015-0692-z","journal-title":"Pituitary"},{"key":"2432_CR80","doi-asserted-by":"publisher","unstructured":"M. Fleseriu, R. Pivonello, A. Elenkova, R. Salvatori, R.J. Auchus, R.A. Feelders, E.B. Geer, Y. Greenman, P. Witek, F. Cohen, B.M.K. Biller, Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing\u2019s syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial. Lancet Diabetes Endocrinol. (2019). https:\/\/doi.org\/10.1016\/s2213-8587(19)30313-4","DOI":"10.1016\/s2213-8587(19)30313-4"},{"issue":"4","key":"2432_CR81","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/cpdd.389","volume":"7","author":"H Hunt","year":"2018","unstructured":"H. Hunt, K. Donaldson, M. Strem, V. Zann, P. Leung, S. Sweet, A. Connor, D. Combs, J. Belanoff, Assessment of safety, tolerability, pharmacokinetics, and pharmacological effect of orally administered CORT125134: an adaptive, double-blind, randomized, placebo-controlled phase 1 clinical study. Clin. Pharmacol. Drug Dev. 7(4), 408\u2013421 (2018). https:\/\/doi.org\/10.1002\/cpdd.389","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"2432_CR82","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fendo.2018.00164","volume":"9","author":"F Langlois","year":"2018","unstructured":"F. Langlois, J. Chu, M. Fleseriu, Pituitary-directed therapies for cushing\u2019s disease. Front. Endocrinol 9, 164 (2018). https:\/\/doi.org\/10.3389\/fendo.2018.00164","journal-title":"Front. Endocrinol"},{"issue":"4","key":"2432_CR83","doi-asserted-by":"publisher","first-page":"M23","DOI":"10.1530\/eje-15-0265","volume":"173","author":"M Reincke","year":"2015","unstructured":"M. Reincke, K. Ritzel, A. Osswald, C. Berr, G. Stalla, K. Hallfeldt, N. Reisch, J. Schopohl, F. Beuschlein, A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing\u2019s syndrome. Eur. J. Endocrinol. 173(4), M23\u2013M32 (2015). https:\/\/doi.org\/10.1530\/eje-15-0265","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"2432_CR84","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1210\/jc.2013-1470","volume":"98","author":"K Ritzel","year":"2013","unstructured":"K. Ritzel, F. Beuschlein, A. Mickisch, A. Osswald, H.J. Schneider, J. Schopohl, M. Reincke, Clinical review: outcome of bilateral adrenalectomy in Cushing\u2019s syndrome: a systematic review. J. Clin. Endocrinol. Metab. 98(10), 3939\u20133948 (2013). https:\/\/doi.org\/10.1210\/jc.2013-1470","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2432_CR85","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1530\/eje-14-0214","volume":"171","author":"A Osswald","year":"2014","unstructured":"A. Osswald, E. Plomer, C. Dimopoulou, M. Milian, R. Blaser, K. Ritzel, A. Mickisch, F. Knerr, M. Stanojevic, K. Hallfeldt, J. Schopohl, K.A. Kuhn, G. Stalla, F. Beuschlein, M. Reincke, Favorable long-term outcomes of bilateral adrenalectomy in Cushing\u2019s disease. Eur. J. Endocrinol. 171(2), 209\u2013215 (2014). https:\/\/doi.org\/10.1530\/eje-14-0214","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"2432_CR86","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11102-005-1403-y","volume":"7","author":"G Assi\u00e9","year":"2004","unstructured":"G. Assi\u00e9, H. Bahurel, J. Bertherat, M. Kujas, P. Legmann, X. Bertagna, The Nelson\u2019s syndrome revisited. Pituitary 7(4), 209\u2013215 (2004). https:\/\/doi.org\/10.1007\/s11102-005-1403-y","journal-title":"Pituitary"},{"issue":"2","key":"2432_CR87","doi-asserted-by":"publisher","first-page":"E14","DOI":"10.3171\/2014.10.focus14681","volume":"38","author":"J Patel","year":"2015","unstructured":"J. Patel, J.A. Eloy, J.K. Liu, Nelson\u2019s syndrome: a review of the clinical manifestations, pathophysiology, and treatment strategies. Neurosurg. Focus 38(2), E14 (2015). https:\/\/doi.org\/10.3171\/2014.10.focus14681","journal-title":"Neurosurg. Focus"},{"issue":"2","key":"2432_CR88","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.surg.2006.12.003","volume":"141","author":"A Gil-C\u00e1rdenas","year":"2007","unstructured":"A. Gil-C\u00e1rdenas, M.F. Herrera, A. D\u00edaz-Polanco, J.M. Rios, J.P. Pantoja, Nelson\u2019s syndrome after bilateral adrenalectomy for Cushing\u2019s disease. Surgery 141(2), 147\u2013151 (2007). https:\/\/doi.org\/10.1016\/j.surg.2006.12.003. discussion 151-142","journal-title":"Surgery"},{"issue":"5","key":"2432_CR89","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1210\/js.2019-00090","volume":"3","author":"J Park","year":"2019","unstructured":"J. Park, A. De Luca, H. Dutton, J.C. Malcolm, M.A. Doyle, Cardiovascular outcomes in autonomous cortisol secretion and nonfunctioning adrenal adenoma: a systematic review. J. Endocr. Soc. 3(5), 996\u20131008 (2019). https:\/\/doi.org\/10.1210\/js.2019-00090","journal-title":"J. Endocr. Soc."},{"issue":"10","key":"2432_CR90","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.4158\/ep161380.or","volume":"22","author":"TB Carroll","year":"2016","unstructured":"T.B. Carroll, B.R. Javorsky, J.W. Findling, Postsurgical recurrent Cushing disease: clinical benefit of early intervention in patients with normal urinary free cortisol. Endocr. Pract. 22(10), 1216\u20131223 (2016). https:\/\/doi.org\/10.4158\/ep161380.or","journal-title":"Endocr. Pract."},{"issue":"3","key":"2432_CR91","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1210\/jc.2012-2893","volume":"98","author":"JK Lambert","year":"2013","unstructured":"J.K. Lambert, L. Goldberg, S. Fayngold, J. Kostadinov, K.D. Post, E.B. Geer, Predictors of mortality and long-term outcomes in treated Cushing\u2019s disease: a study of 346 patients. J. Clin. Endocrinol. Metab. 98(3), 1022\u20131030 (2013). https:\/\/doi.org\/10.1210\/jc.2012-2893","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2432_CR92","doi-asserted-by":"publisher","unstructured":"J. Newell-Price, L.K. Nieman, M. Reincke, A. Tabarin, Endocrinology in the time of COVID-19: management of Cushing\u2019s syndrome. Eur. J. Endocrinol. 183(1), G1\u2013G7 (2020). https:\/\/doi.org\/10.1530\/EJE-20-0352","DOI":"10.1530\/EJE-20-0352"},{"issue":"7","key":"2432_CR93","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1210\/jc.2007-2734","volume":"93","author":"BM Biller","year":"2008","unstructured":"B.M. Biller, A.B. Grossman, P.M. Stewart, S. Melmed, X. Bertagna, J. Bertherat, M. Buchfelder, A. Colao, A.R. Hermus, L.J. Hofland, A. Klibanski, A. Lacroix, J.R. Lindsay, J. Newell-Price, L.K. Nieman, S. Petersenn, N. Sonino, G.K. Stalla, B. Swearingen, M.L. Vance, J.A. Wass, M. Boscaro, Treatment of adrenocorticotropin-dependent Cushing\u2019s syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 93(7), 2454\u20132462 (2008). https:\/\/doi.org\/10.1210\/jc.2007-2734","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2432_CR94","first-page":"168","volume":"62","author":"F Cavagnini","year":"2001","unstructured":"F. Cavagnini, F. Pecori Giraldi, Epidemiology and follow-up of Cushing\u2019s disease. Annales d\u2019endocrinologie 62(2), 168\u2013172 (2001)","journal-title":"Annales d\u2019endocrinologie"},{"issue":"1","key":"2432_CR95","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1055\/s-2003-37145","volume":"64","author":"J Flitsch","year":"2003","unstructured":"J. Flitsch, U.J. Knappe, D.K. L\u00fcdecke, The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing\u2019s disease. Zentralblatt fur Neurochirurgie 64(1), 6\u201311 (2003). https:\/\/doi.org\/10.1055\/s-2003-37145","journal-title":"Zentralblatt fur Neurochirurgie"},{"issue":"12","key":"2432_CR96","doi-asserted-by":"publisher","first-page":"6348","DOI":"10.1210\/jc.2003-032180","volume":"89","author":"GD Hammer","year":"2004","unstructured":"G.D. Hammer, J.B. Tyrrell, K.R. Lamborn, C.B. Applebury, E.T. Hannegan, S. Bell, R. Rahl, A. Lu, C.B. Wilson, Transsphenoidal microsurgery for Cushing\u2019s disease: initial outcome and long-term results. J. Clin. Endocrinol. Metab. 89(12), 6348\u20136357 (2004). https:\/\/doi.org\/10.1210\/jc.2003-032180","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2432_CR97","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1530\/eje-13-0634","volume":"170","author":"C Dimopoulou","year":"2014","unstructured":"C. Dimopoulou, J. Schopohl, W. Rachinger, M. Buchfelder, J. Honegger, M. Reincke, G.K. Stalla, Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing\u2019s disease: care reality in the Munich Metropolitan Region. Eur. J. Endocrinol. 170(2), 283\u2013292 (2014). https:\/\/doi.org\/10.1530\/eje-13-0634","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"2432_CR98","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1210\/jcem.84.2.5465","volume":"84","author":"C Invitti","year":"1999","unstructured":"C. Invitti, F. Pecori Giraldi, M. de Martin, F. Cavagnini, Diagnosis and management of Cushing\u2019s syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. T J. Clin. Endocrinol. Metab. 84(2), 440\u2013448 (1999). https:\/\/doi.org\/10.1210\/jcem.84.2.5465","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2432_CR99","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3171\/2008.8.jns08339","volume":"111","author":"J Jagannathan","year":"2009","unstructured":"J. Jagannathan, R. Smith, H.L. DeVroom, A.O. Vortmeyer, C.A. Stratakis, L.K. Nieman, E.H. Oldfield, Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease. J. Neurosurg. 111(3), 531\u2013539 (2009). https:\/\/doi.org\/10.3171\/2008.8.jns08339","journal-title":"J. Neurosurg."},{"issue":"12","key":"2432_CR100","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1210\/jc.2008-0979","volume":"93","author":"S Jehle","year":"2008","unstructured":"S. Jehle, J.E. Walsh, P.U. Freda, K.D. Post, Selective use of bilateral inferior petrosal sinus sampling in patients with adrenocorticotropin-dependent Cushing\u2019s syndrome prior to transsphenoidal surgery. J. Clin. Endocrinol. Metab. 93(12), 4624\u20134632 (2008). https:\/\/doi.org\/10.1210\/jc.2008-0979","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"2432_CR101","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1590\/s0004-27302007000800022","volume":"51","author":"G Rollin","year":"2007","unstructured":"G. Rollin, N.P. Ferreira, M.A. Czepielewski, Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing\u2019s disease. Arq Brasileiros de Endocrinol. e Metabologia 51(8), 1355\u20131361 (2007). https:\/\/doi.org\/10.1590\/s0004-27302007000800022","journal-title":"Arq Brasileiros de Endocrinol. e Metabologia"},{"issue":"7","key":"2432_CR102","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1210\/jcem.81.7.8675592","volume":"81","author":"N Sonino","year":"1996","unstructured":"N. Sonino, M. Zielezny, G.A. Fava, F. Fallo, M. Boscaro, Risk factors and long-term outcome in pituitary-dependent Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 81(7), 2647\u20132652 (1996). https:\/\/doi.org\/10.1210\/jcem.81.7.8675592","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"2432_CR103","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s11102-017-0802-1","volume":"20","author":"PC Johnston","year":"2017","unstructured":"P.C. Johnston, L. Kennedy, A.H. Hamrahian, Z. Sandouk, J. Bena, B. Hatipoglu, R.J. Weil, Surgical outcomes in patients with Cushing\u2019s disease: the Cleveland clinic experience. Pituitary 20(4), 430\u2013440 (2017)","journal-title":"Pituitary"},{"issue":"2","key":"2432_CR104","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1227\/NEU.0000000000001011","volume":"78","author":"WF Chandler","year":"2016","unstructured":"W.F. Chandler, A.L. Barkan, T. Hollon, A. Sakharova, J. Sack, B. Brahma, D.E. Schteingart, Outcome of transsphenoidal surgery for Cushing Disease: a single-center experience over 32 Years. Neurosurgery 78(2), 216\u2013223 (2016)","journal-title":"Neurosurgery"},{"issue":"4","key":"2432_CR105","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1530\/eje-12-0921","volume":"168","author":"KI Alexandraki","year":"2013","unstructured":"K.I. Alexandraki, G.A. Kaltsas, A.M. Isidori, H.L. Storr, F. Afshar, I. Sabin, S.A. Akker, S.L. Chew, W.M. Drake, J.P. Monson, G.M. Besser, A.B. Grossman, Long-term remission and recurrence rates in Cushing\u2019s disease: predictive factors in a single-centre study. Eur. J. Endocrinol. 168(4), 639\u2013648 (2013). https:\/\/doi.org\/10.1530\/eje-12-0921","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"2432_CR106","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1530\/EC-17-0175","volume":"6","author":"P Bansal","year":"2017","unstructured":"P. Bansal, A. Lila, M. Goroshi, S. Jadhav, N. Lomte, K. Thakkar, A. Goel, A. Shah, S. Sankhe, N. Goel, N. Jaguste, T. Bandgar, N. Shah, Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing\u2019s disease. Endocr. Connect. 6(8), 625\u2013636 (2017)","journal-title":"Endocr. Connect."},{"issue":"2","key":"2432_CR107","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3171\/jns.1983.59.2.0195","volume":"59","author":"JE Boggan","year":"1983","unstructured":"J.E. Boggan, J.B. Tyrrell, C.B. Wilson, Transsphenoidal microsurgical management of Cushing\u2019s disease. Report of 100 cases. J. Neurosurg. 59(2), 195\u2013200 (1983). https:\/\/doi.org\/10.3171\/jns.1983.59.2.0195","journal-title":"J. Neurosurg."},{"issue":"5","key":"2432_CR108","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1530\/eje-11-0424","volume":"165","author":"R Bou Khalil","year":"2011","unstructured":"R. Bou Khalil, C. Baudry, L. Guignat, C. Carrasco, J. Guibourdenche, S. Gaillard, X. Bertagna, J. Bertherat, Sequential hormonal changes in 21 patients with recurrent Cushing\u2019s disease after successful pituitary surgery. Eur. J. Endocrinol. 165(5), 729\u2013737 (2011). https:\/\/doi.org\/10.1530\/eje-11-0424","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"2432_CR109","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3171\/jns.2003.98.5.0967","volume":"98","author":"JC Chen","year":"2003","unstructured":"J.C. Chen, A.P. Amar, S. Choi, P. Singer, W.T. Couldwell, M.H. Weiss, Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J. Neurosurg. 98(5), 967\u2013973 (2003). https:\/\/doi.org\/10.3171\/jns.2003.98.5.0967","journal-title":"J. Neurosurg."},{"key":"2432_CR110","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000091580","volume":"34","author":"BM Hofmann","year":"2006","unstructured":"B.M. Hofmann, R. Fahlbusch, Treatment of Cushing\u2019s disease: a retrospective clinical study of the latest 100 cases. Front. Horm. Res. 34, 158\u2013184 (2006). https:\/\/doi.org\/10.1159\/000091580","journal-title":"Front. Horm. Res."},{"key":"2432_CR111","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-7091-9450-8_10","volume":"65","author":"UJ Knappe","year":"1996","unstructured":"U.J. Knappe, D.K. L\u00fcdecke, Persistent and recurrent hypercortisolism after transsphenoidal surgery for Cushing\u2019s disease. Acta Neurochirurgica 65, 31\u201334 (1996). https:\/\/doi.org\/10.1007\/978-3-7091-9450-8_10","journal-title":"Acta Neurochirurgica"},{"issue":"2","key":"2432_CR112","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1227\/00006123-198708000-00015","volume":"21","author":"T Nakane","year":"1987","unstructured":"T. Nakane, A. Kuwayama, M. Watanabe, T. Takahashi, T. Kato, K. Ichihara, N. Kageyama, Long term results of transsphenoidal adenomectomy in patients with Cushing\u2019s disease. Neurosurgery 21(2), 218\u2013222 (1987). https:\/\/doi.org\/10.1227\/00006123-198708000-00015","journal-title":"Neurosurgery"},{"issue":"4","key":"2432_CR113","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3171\/jns\/2008\/109\/10\/0751","volume":"109","author":"DM Prevedello","year":"2008","unstructured":"D.M. Prevedello, N. Pouratian, J. Sherman, J.A. Jane Jr., M.L. Vance, M.B. Lopes, E.R. Laws Jr., Management of Cushing\u2019s disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging. J. Neurosurg. 109(4), 751\u2013759 (2008). https:\/\/doi.org\/10.3171\/jns\/2008\/109\/10\/0751","journal-title":"J. Neurosurg."},{"issue":"2","key":"2432_CR114","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1210\/jc.2009-1672","volume":"95","author":"E Valassi","year":"2010","unstructured":"E. Valassi, B.M. Biller, B. Swearingen, F. Pecori Giraldi, M. Losa, P. Mortini, D. Hayden, F. Cavagnini, A. Klibanski, Delayed remission after transsphenoidal surgery in patients with Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 95(2), 601\u2013610 (2010). https:\/\/doi.org\/10.1210\/jc.2009-1672","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2432_CR115","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/j.wneu.2017.09.105","volume":"109","author":"M Feng","year":"2018","unstructured":"M. Feng, Z. Liu, X. Liu, X. Bao, Y. Yao, K. Deng, B. Xing, W. Lian, H. Zhu, L. Lu, R. Wang, Diagnosis and outcomes of 341 patients with Cushing\u2019s disease following transsphenoid surgery: a single-center experience. World Neurosurg. 109, e75\u2013e80 (2018). https:\/\/doi.org\/10.1016\/j.wneu.2017.09.105","journal-title":"World Neurosurg."},{"issue":"3","key":"2432_CR116","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/eje.0.1490195","volume":"149","author":"S Cannav\u00f2","year":"2003","unstructured":"S. Cannav\u00f2, B. Almoto, C. Dall\u2019Asta, S. Corsello, R.M. Lovicu, E. De Menis, F. Trimarchi, B. Ambrosi, Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas. Eur. J. Endocrinol. 149(3), 195\u2013200 (2003). https:\/\/doi.org\/10.1530\/eje.0.1490195","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"2432_CR117","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/jcem-69-6-1122","volume":"69","author":"GF Pieters","year":"1989","unstructured":"G.F. Pieters, A.R. Hermus, E. Meijer, A.G. Smals, P.W. Kloppenborg, Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 69(6), 1122\u20131126 (1989)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"2432_CR118","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1210\/jc.2011-0456","volume":"96","author":"JR Lindsay","year":"2011","unstructured":"J.R. Lindsay, E.H. Oldfield, C.A. Stratakis, L.K. Nieman, The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing\u2019s disease after transsphenoidal surgery. J. Clin. Endocrinol. Metab. 96(7), 2057\u20132064 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2432_CR119","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11102-014-0567-8","volume":"18","author":"G Aranda","year":"2015","unstructured":"G. Aranda, J. Ense\u00f1at, M. Mora, M. Puig-Domingo, M.J. Mart\u00ednez de Osaba, G. Casals, E. Verger, M.T. Ribalta, F.A. Hanzu, I. Halperin, Long-term remission and recurrence rate in a cohort of Cushing\u2019s disease: the need for long-term follow-up. Pituitary 18(1), 142\u2013149 (2015). https:\/\/doi.org\/10.1007\/s11102-014-0567-8","journal-title":"Pituitary"},{"issue":"1","key":"2432_CR120","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1507\/endocrj.48.53","volume":"48","author":"T Imaki","year":"2001","unstructured":"T. Imaki, T. Tsushima, N. Hizuka, E. Odagiri, Y. Murata, T. Suda, K. Takano, Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing\u2019s disease and determine which patients should be treated with pituitary irradiation after surgery. Endocr. J. 48(1), 53\u201362 (2001)","journal-title":"Endocr. J."},{"issue":"3","key":"2432_CR121","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1530\/EJE-17-0873","volume":"178","author":"N Ironside","year":"2018","unstructured":"N. Ironside, G. Chatain, D. Asuzu, S. Benzo, M. Lodish, S. Sharma, L. Nieman, C.A. Stratakis, R.R. Lonser, P. Chittiboina, Earlier post-operative hypocortisolemia may predict durable remission from Cushing\u2019s disease. Eur. J. Endocrinol. 178(3), 255\u2013263 (2018)","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"2432_CR122","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3171\/2017.6.JNS17635","volume":"129","author":"M Mayberg","year":"2018","unstructured":"M. Mayberg, S. Reintjes, A. Patel, K. Moloney, J. Mercado, A. Carlson, J. Scanlan, F. Broyles, Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing\u2019s disease: implications for immediate reoperation and remission. J. Neurosurg. 129(5), 1268\u20131277 (2018)","journal-title":"J. Neurosurg."},{"issue":"2","key":"2432_CR123","first-page":"291","volume":"76","author":"GC Toms","year":"1993","unstructured":"G.C. Toms, M.I. McCarthy, M.J. Niven, C.H. Orteu, T.T. King, J.P. Monson, Predicting relapse after transsphenoidal surgery for Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 76(2), 291\u2013294 (1993)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"2432_CR124","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1530\/EC-19-0297","volume":"8","author":"P Abell\u00e1n-Galiana","year":"2019","unstructured":"P. Abell\u00e1n-Galiana, C. Fajardo-Monta\u00f1ana, P. Riesgo-Su\u00e1rez, M. P\u00e9rez-Bermejo, C. R\u00edos-P\u00e9rez, J. G\u00f3mez-Vela, Prognostic usefulness of ACTH in the postoperative period of Cushing\u2019s disease. Endocr. Connect. 8(9), 1262\u20131272 (2019)","journal-title":"Endocr. Connect."},{"issue":"5","key":"2432_CR125","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s40618-019-01151-1","volume":"43","author":"AL Serban","year":"2020","unstructured":"A.L. Serban, G. Del Sindaco, E. Sala, G. Carosi, R. Indirli, G. Rodari, C. Giavoli, M. Locatelli, G. Carrabba, G. Bertani, G. Marfia, G. Mantovani, M. Arosio, E. Ferrante, Determinants of outcome of transsphenoidal surgery for Cushing disease in a single-centre series. J. Endocrinol. Investig. 43(5), 631\u2013639 (2020)","journal-title":"J. Endocrinol. Investig."},{"issue":"1","key":"2432_CR126","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/jnrp.jnrp_308_17","volume":"9","author":"A Selek","year":"2018","unstructured":"A. Selek, B. Cetinarslan, Z. Canturk, I. Tarkun, O.Z. Akyay, B. Cabuk, S. Ceylan, The utility of preoperative ACTH\/cortisol ratio for the diagnosis and prognosis of cushing\u2019s disease. J. Neurosci. Rural Pract. 9(1), 106\u2013111 (2018)","journal-title":"J. Neurosci. Rural Pract."},{"issue":"4","key":"2432_CR127","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1046\/j.1365-2265.2002.01511.x","volume":"56","author":"DA Rees","year":"2002","unstructured":"D.A. Rees, F.W. Hanna, J.S. Davies, R.G. Mills, J. Vafidis, M.F. Scanlon, Long-term follow-up results of transsphenoidal surgery for Cushing\u2019s disease in a single centre using strict criteria for remission. Clin. Endocrinol. 56(4), 541\u2013551 (2002). https:\/\/doi.org\/10.1046\/j.1365-2265.2002.01511.x","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"2432_CR128","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2265.2007.03168.x","volume":"69","author":"DJ Romanholi","year":"2008","unstructured":"D.J. Romanholi, M.C. Machado, C.C. Pereira, D.S. Danilovic, M.A. Pereira, V.A. Cescato, M.B. Cunha Neto, N.R. Musolino, B.B. de Mendon\u00e7a, L.R. Salgado, Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing\u2019s disease. Clin. Endocrinol. 69(1), 117\u2013122 (2008). https:\/\/doi.org\/10.1111\/j.1365-2265.2007.03168.x","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"2432_CR129","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1530\/eje.0.1510727","volume":"151","author":"R Val\u00e9ro","year":"2004","unstructured":"R. Val\u00e9ro, S. Vallette-Kasic, B. Conte-Devolx, P. Jaquet, T. Brue, The desmopressin test as a predictive factor of outcome after pituitary surgery for Cushing\u2019s disease. Eur. J. Endocrinol. 151(6), 727\u2013733 (2004). https:\/\/doi.org\/10.1530\/eje.0.1510727","journal-title":"Eur. J. Endocrinol."},{"issue":"12","key":"2432_CR130","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1210\/jc.2016-2799","volume":"101","author":"DA Vassiliadi","year":"2016","unstructured":"D.A. Vassiliadi, M. Balomenaki, A. Asimakopoulou, E. Botoula, M. Tzanela, S. Tsagarakis, The desmopressin test predicts better than basal cortisol the long-term surgical outcome of cushing\u2019s disease. J. Clin. Endocrinol. Metab. 101(12), 4878\u20134885 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"2432_CR131","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1210\/jc.2009-0844","volume":"94","author":"M Losa","year":"2009","unstructured":"M. Losa, R. Bianchi, R. Barzaghi, M. Giovanelli, P. Mortini, Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 94(9), 3322\u20133328 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2432_CR132","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/cen.12739","volume":"83","author":"P Le Marc\u2019hadour","year":"2015","unstructured":"P. Le Marc\u2019hadour, M. Muller, F. Albarel, A.L. Coulon, I. Morange, M. Martinie, E. Gay, T. Graillon, H. Dufour, B. Conte-Devolx, O. Chabre, T. Brue, F. Castinetti, Postoperative follow-up of Cushing\u2019s disease using cortisol, desmopressin and coupled dexamethasone-desmopressin tests: a head-to-head comparison. Clin. Endocrinol. 83(2), 216\u2013222 (2015). https:\/\/doi.org\/10.1111\/cen.12739","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"2432_CR133","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/cen.12133","volume":"79","author":"M Barbot","year":"2013","unstructured":"M. Barbot, N. Albiger, S. Koutroumpi, F. Ceccato, A.C. Frigo, R. Manara, A. Fassina, M.P. Gardiman, M. Scanarini, F. Mantero, C. Scaroni, Predicting late recurrence in surgically treated patients with Cushing\u2019s disease. Clin. Endocrinol. 79(3), 394\u2013401 (2013)","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"2432_CR134","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1046\/j.1365-2265.2001.01324.x","volume":"55","author":"M Losa","year":"2001","unstructured":"M. Losa, P. Mortini, S. Dylgjeri, R. Barzaghi, A. Franzin, C. Mandelli, M. Giovanelli, Desmopressin stimulation test before and after pituitary surgery in patients with Cushing\u2019s disease. Clin. Endocrinol. 55(1), 61\u201368 (2001). https:\/\/doi.org\/10.1046\/j.1365-2265.2001.01324.x","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"2432_CR135","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1046\/j.1365-2265.1997.2541051.x","volume":"47","author":"MO van Aken","year":"1997","unstructured":"M.O. van Aken, W.W. de Herder, A.J. van der Lely, F.H. de Jong, S.W: Lamberts, Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing\u2019s disease. Clin. Endocrinol. 47(2), 145\u2013149 (1997). https:\/\/doi.org\/10.1046\/j.1365-2265.1997.2541051.x","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"2432_CR136","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s11102-018-0902-6","volume":"21","author":"E Uvelius","year":"2018","unstructured":"E. Uvelius, P. H\u00f6glund, S. Valdemarsson, P. Siesj\u00f6, An early post-operative ACTH suppression test can safely predict short- and long-term remission after surgery of Cushing\u2019s disease. Pituitary 21(5), 490\u2013498 (2018). https:\/\/doi.org\/10.1007\/s11102-018-0902-6","journal-title":"Pituitary"},{"issue":"4","key":"2432_CR137","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1210\/jc.2012-3200","volume":"98","author":"X Bertagna","year":"2013","unstructured":"X. Bertagna, L. Guignat, Approach to the Cushing\u2019s disease patient with persistent\/recurrent hypercortisolism after pituitary surgery. J. Clin. Endocrinol. Metab. 98(4), 1307\u20131318 (2013). https:\/\/doi.org\/10.1210\/jc.2012-3200","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2432_CR138","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ecl.2014.10.006","volume":"44","author":"M Fleseriu","year":"2015","unstructured":"M. Fleseriu, Medical treatment of Cushing disease: new targets, new hope. Endocrinol. Metab. Clinics North Am. 44(1), 51\u201370 (2015). https:\/\/doi.org\/10.1016\/j.ecl.2014.10.006","journal-title":"Endocrinol. Metab. Clinics North Am."},{"issue":"2","key":"2432_CR139","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11102-014-0627-0","volume":"18","author":"M Fleseriu","year":"2015","unstructured":"M. Fleseriu, S. Petersenn, Medical therapy for Cushing\u2019s disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockers. Pituitary 18(2), 245\u2013252 (2015). https:\/\/doi.org\/10.1007\/s11102-014-0627-0","journal-title":"Pituitary"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02432-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-020-02432-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02432-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T19:49:52Z","timestamp":1627847392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-020-02432-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,2]]},"references-count":139,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["2432"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02432-z","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,2]]},"assertion":[{"value":"13 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}